LEXX Competitors & Alternatives
Compare Lexaria Bioscience Corp with similar stocks in the same industry
Biotechnology
LEXX
Main Stock$4.41
-0.68%
Tradestie Score
32
Market Cap
$21.68M
Revenue Growth
-88.5%
Analyst Upside
+1770.7%
Supply-Chain & Ecosystem Map (Customers, Suppliers & Direct Competitors)
Bottleneck Score: 2/10
Drug Discovery Biotech
Drug Design
Major Customers
3
pharmaceutical licensees
cannabis product manufacturers
nicotine delivery companies
Critical Suppliers
2
API manufacturers
contract research organizations
Direct Ecosystem Rivals
1
Top Competitors
219 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
SRZN
Surrozen, Inc. Common
|
$32.32
+2.25%
|
$117.07M | - | 33 | Compare |
|
ANRO
Alto Neuroscience Inc.
|
$27.12
-8.19%
|
$110.20M | - | 32 | Compare |
|
ENTX
Entera Bio Ltd. Ordinary Shares
|
$3.02
-2.89%
|
$84.52M | - | 53 | Compare |
|
IMMX
Immix Biopharma, Inc. Common Stock
|
$7.48
-4.59%
|
$67.94M | - | 52 | Compare |
|
KTTA
Pasithea Therapeutics Corp. Common Stock
|
$0.50
-4.21%
|
$5.73M | - | 38 | Compare |
|
INM
InMed Pharmaceuticals Inc. Common Shares
|
$15.56
+17.79%
|
$5.29M | - | 35 | Compare |
|
PRFX
PainReform Ltd. Ordinary Shares
|
$0.69
-11.22%
|
$2.78M | - | 36 | Compare |
|
NMAD
NMAD
|
$2.80
+19.15%
|
- | - | 44 | Compare |
|
VRPX
VRPX
|
- | - | - | - | Compare |
|
none major public tickers
none major public tickers
|
- | - | - | - | Compare |
More LEXX Analysis
Data updated: Nov 16, 2026 | Industry: Biotechnology (SIC 2834)
219 stocks in this industry